90 DAYS: An Entertainment Education Intervention to Evaluate a Short Film About HIV Status Disclosure

Not Applicable

Completed

• Conditions: HIV/AIDS
• Interventions: Behavioral: 90 DAYS film; Behavioral: HIV pamphlet on disclosure

• Registration Number: NCT03898063
• Lead Sponsor: University of Miami

Brief Summary

This investigation seeks to understand if and how, the 90 Days film can be used as an intervention to address HIV-related stigmas, intimate partner status disclosure and HIV ART medical adherence among Black HIV positive women.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2019-03-29
• Study First Submitted QC: 2019-03-29
• Study First Posted: 2019-04-01
• Study Start: 2019-06-17
• Primary Completion: 2020-05-31
• Study Completion: 2020-05-31
• Results First Submitted: 2021-05-17
• Status Verified: 2021-06
• Results First Submitted QC: 2021-06-11
• Last Update Submitted: 2021-06-11
• Results First Posted: 2021-07-02
• Last Update Posted: 2021-07-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 148

Inclusion Criteria

• Black women ages 18-50
• clinically diagnosed with HIV/AIDS
• Speak and comprehend English

Read More

Exclusion Criteria

• pregnant women

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
intervention: 90 DAYS film	90 DAYS film	participants will watch the film, 90 DAYS
Control	HIV pamphlet on disclosure	participants will receive a standard-of-care brochure detailing HIV status disclosure.

Primary Outcome Measures

Name	Time	Method
HIV Disclosure Intentions as Assessed by Disclosure Intentions Scale	Day 1 post-test	Self-report measure of the extent to which participants intend to disclose their HIV status to a partner. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher intentions of status disclosure.
HIV Self-stigmatization as Assessed Via Self Stigmatization Questionnaire	Day 1 post test	self-report measure of the extent to which participants stigmatize themselves for being HIV positive. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating higher perceptions of self-stigmatization.
Medical Adherence Intentions as Measured by the Medical Adherence Scale	Day 1 post-test	Self-report measure of participants likeliness to miss doses of their antiretroviral medication over a 30 day period. Quantified in the manuscript using the mean of the self-report scale. Scores range from 1-5 with higher scores indicating increased likeliness to miss doses of antiretroviral medication.

Trial Locations

Locations (1)

University of Miami Medical Campus; 🇺🇸 Miami, Florida, United States